Müller MR - Search Results

1

The use of dendritic cells in cancer immunotherapy.

Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: muller mr. Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. doi: 10.1016/j.critrevonc.2007.10.002. Epub 2007 Dec 4. Crit Rev Oncol Hematol. 2008. PMID: 18055210 Review.

2

Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.

Milazzo C, Reichardt VL, Müller MR, Grünebach F, Brossart P. Milazzo C, et al. Among authors: muller mr. Blood. 2003 Feb 1;101(3):977-82. doi: 10.1182/blood-2002-04-1273. Epub 2002 Sep 19. Blood. 2003. PMID: 12393470 Free article.

3

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

Schmidt SM, Schag K, Müller MR, Weck MM, Appel S, Kanz L, Grünebach F, Brossart P. Schmidt SM, et al. Among authors: muller mr. Blood. 2003 Jul 15;102(2):571-6. doi: 10.1182/blood-2002-08-2554. Epub 2003 Feb 6. Blood. 2003. PMID: 12576330 Free article.

4

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.

Grünebach F, Müller MR, Nencioni A, Brossart P. Grünebach F, et al. Among authors: muller mr. Gene Ther. 2003 Mar;10(5):367-74. doi: 10.1038/sj.gt.3301901. Gene Ther. 2003. PMID: 12601391

5

Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer.

Nencioni A, Müller MR, Grünebach F, Garuti A, Mingari MC, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: muller mr. Cancer Gene Ther. 2003 Mar;10(3):209-14. doi: 10.1038/sj.cgt.7700557. Cancer Gene Ther. 2003. PMID: 12637942

6

Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.

Müller MR, Grünebach F, Nencioni A, Brossart P. Müller MR, et al. J Immunol. 2003 Jun 15;170(12):5892-6. doi: 10.4049/jimmunol.170.12.5892. J Immunol. 2003. PMID: 12794115

7

Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches.

Müller MR, Grünebach F, Kayser K, Vogel W, Nencioni A, Brugger W, Kanz L, Brossart P. Müller MR, et al. Clin Cancer Res. 2003 Aug 15;9(9):3448-53. Clin Cancer Res. 2003. PMID: 12960136

8

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

Appel S, Boehmler AM, Grünebach F, Müller MR, Rupf A, Weck MM, Hartmann U, Reichardt VL, Kanz L, Brümmendorf TH, Brossart P. Appel S, et al. Among authors: muller mr. Blood. 2004 Jan 15;103(2):538-44. doi: 10.1182/blood-2003-03-0975. Epub 2003 Sep 22. Blood. 2004. PMID: 14504105 Free article.

9

Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells.

Müller MR, Tsakou G, Grünebach F, Schmidt SM, Brossart P. Müller MR, et al. Blood. 2004 Mar 1;103(5):1763-9. doi: 10.1182/blood-2003-06-2097. Epub 2003 Nov 13. Blood. 2004. PMID: 14615377 Free article.

10

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

Schmidt SM, Schag K, Müller MR, Weinschenk T, Appel S, Schoor O, Weck MM, Grünebach F, Kanz L, Stevanovic S, Rammensee HG, Brossart P. Schmidt SM, et al. Among authors: muller mr. Cancer Res. 2004 Feb 1;64(3):1164-70. doi: 10.1158/0008-5472.can-03-2538. Cancer Res. 2004. PMID: 14871853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters